CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-20 | CELGENE CORP /DE/ 10% owner | Sale | −158,718 | $19.02 | $3.0M | 4,253,019 |
| 2017-11-17 | CELGENE CORP /DE/ 10% owner | Sale | −51,282 | $18.44 | $946K | 4,411,737 |
| 2017-11-16 | CELGENE CORP /DE/ 10% owner | Sale | −105,000 | $18.39 | $1.9M | 4,463,019 |
| 2017-11-15 | CELGENE CORP /DE/ 10% owner | Sale | −15,000 | $17.67 | $265K | 4,568,019 |
| 2017-11-14 | CELGENE CORP /DE/ 10% owner | Sale | −14,907 | $17.19 | $256K | 4,583,019 |
| 2017-11-13 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −12,000 | 168,000 | ||
| 2017-11-13 | CELGENE CORP /DE/ 10% owner | Sale | −65,093 | $17.76 | $1.2M | 4,597,926 |
| 2017-11-13 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2017-11-10 | CELGENE CORP /DE/ 10% owner | Sale | −10,000 | $17.28 | $173K | 4,663,019 |
| 2017-11-09 | CELGENE CORP /DE/ 10% owner | Sale | −20,000 | $17.08 | $342K | 4,673,019 |
| 2017-11-08 | CELGENE CORP /DE/ 10% owner | Sale | −16,875 | $18.06 | $305K | 4,693,019 |
| 2017-11-07 | CELGENE CORP /DE/ 10% owner | Sale | −23,000 | $18.54 | $426K | 4,709,894 |
| 2017-11-06 | CELGENE CORP /DE/ 10% owner | Sale | −79,327 | $18.89 | $1.5M | 4,732,894 |
| 2017-11-03 | CELGENE CORP /DE/ 10% owner | Sale | −22,759 | $19.10 | $435K | 4,812,221 |
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −1,368,013 | 2,736,032 | ||
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −8,110 | 16,224 | ||
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −814,599 | 1,629,204 | ||
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −23,899 | 47,801 | ||
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −61,993 | 123,994 | ||
| 2017-09-05 | Versant Venture Capital IV, L.P. 10% owner | Other disposition | −26,491 | 52,987 |
Page 58 of 62 · 1,221 trades